ALNYLAM PHARMACEUTICALS, INC. reports stock sale.
- Supran Bryan sold 1,758 shares on 10/02/2026
- Shares sold at $226.88 each
- 12,807 shares remain beneficially owned
Bryan Supran, reporting
Every EDGAR filing for ALNYLAM PHARMACEUTICALS, INC. (ALNY), newest first, with AI summaries and stories.
Next: earnings expected ~Nov 2 · 10-Q expected ~Nov 2 (deadline Nov 9)
No open-market insider buys in the last 30 days.
Also: 1 open-market sale ($399K), 1 grant or exercise.
Bryan Supran, reporting
Bryan Supran
Yvonne Greenstreet, insider filing for ALNY
Yvonne Greenstreet, reporting
David E I Pyott, insider filing for ALNY
David E I Pyott, reporting
David E I Pyott, planned sale of ALNY shares
David E I Pyott, reporting
Charles Elliott Sigal, insider filing for ALNY
Charles Elliott Sigal, reporting
Amy W Schulman, insider filing for ALNY
Amy W Schulman, reporting
Ownership stake disclosure by Capital World Investors (amended)
Capital World Investors, filed by
Ownership stake disclosure by Capital Research Global Investors (amended)
Capital Research Global Investors, filed by
Ownership stake disclosure by FMR LLC (amended)
FMR LLC, filed by
Ownership stake disclosure by VANGUARD CAPITAL MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC, filed by
Melissa McLaughlin, insider filing for ALNY
Melissa McLaughlin, reporting
Melissa McLaughlin, planned sale of ALNY shares
Melissa McLaughlin, reporting
Ownership stake disclosure by VANGUARD GROUP INC (amended)
VANGUARD GROUP INC, filed by
Pushkal Garg, insider filing for ALNY
Pushkal Garg, reporting
Kevin Joseph Fitzgerald, planned sale of ALNY shares
Kevin Joseph Fitzgerald, reporting
Jeffrey V. Poulton, insider filing for ALNY
Jeffrey Poulton V., reporting
Kevin Joseph Fitzgerald, planned sale of ALNY shares
Kevin Joseph Fitzgerald, reporting
Yvonne Greenstreet, insider filing for ALNY
Yvonne Greenstreet, reporting